{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T22:29:52Z","timestamp":1793312992550,"version":"4.5.0"},"reference-count":79,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T00:00:00Z","timestamp":1733443200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000923","name":"Australian Research Council","doi-asserted-by":"publisher","award":["CE140100036"],"award-info":[{"award-number":["CE140100036"]}],"id":[{"id":"10.13039\/501100000923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016887","name":"Motor Neurone Disease Research Australia","doi-asserted-by":"publisher","award":["BG2107"],"award-info":[{"award-number":["BG2107"]}],"id":[{"id":"10.13039\/100016887","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016887","name":"Motor Neurone Disease Research Australia","doi-asserted-by":"publisher","award":["IG2060"],"award-info":[{"award-number":["IG2060"]}],"id":[{"id":"10.13039\/100016887","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014012","name":"FightMND","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014012","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1148582"],"award-info":[{"award-number":["APP1148582"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.jconrel.2024.11.074","type":"journal-article","created":{"date-parts":[[2024,12,13]],"date-time":"2024-12-13T07:46:43Z","timestamp":1734076003000},"page":"221-235","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"special_numbering":"C","title":["Lipid nanoparticles and transcranial focused ultrasound enhance the delivery of SOD1 antisense oligonucleotides to the murine brain for ALS therapy"],"prefix":"10.1016","volume":"378","author":[{"given":"Gayathri R.","family":"Ediriweera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amal J.","family":"Sivaram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Cowin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikayla L.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke","family":"McAlary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy S.","family":"Lum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas L.","family":"Fletcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liam","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua D.","family":"Simpson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liyu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna M.","family":"Wasielewska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ella","family":"Byrne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John W.","family":"Finnie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jim","family":"Manavis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony R.","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin J.","family":"Yerbury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristofer J.","family":"Thurecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kara L.","family":"Vine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2024.11.074_bb0005","doi-asserted-by":"crossref","first-page":"17071","DOI":"10.1038\/nrdp.2017.71","article-title":"Amyotrophic lateral sclerosis","volume":"3","author":"Hardiman","year":"2017","journal-title":"Nat. Rev. Dis. Primers."},{"key":"10.1016\/j.jconrel.2024.11.074_bb0010","first-page":"181","article-title":"Risk factors for amyotrophic lateral sclerosis","volume":"7","author":"Ingre","year":"2015","journal-title":"Clin. Epidemiol."},{"key":"10.1016\/j.jconrel.2024.11.074_bb0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12883-021-02187-8","article-title":"Prediction of survival in amyotrophic lateral sclerosis: a nationwide, Danish cohort study","volume":"21","author":"Kj\u00e6ldgaard","year":"2021","journal-title":"BMC Neurol."},{"key":"10.1016\/j.jconrel.2024.11.074_bb0020","doi-asserted-by":"crossref","first-page":"6534150","DOI":"10.1155\/2018\/6534150","article-title":"Maximizing the survival of amyotrophic lateral sclerosis patients: current perspectives","volume":"2018","author":"Khairoalsindi","year":"2018","journal-title":"Neurol. Res. Int."},{"key":"10.1016\/j.jconrel.2024.11.074_bb0025","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.bbr.2010.04.042","article-title":"Significance of behavioural tests in a transgenic mouse model of amyotrophic lateral sclerosis (ALS)","volume":"213","author":"Knippenberg","year":"2010","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.jconrel.2024.11.074_bb0030","article-title":"Prion-like propagation of protein misfolding and aggregation in amyotrophic lateral sclerosis","volume":"262","author":"McAlary","year":"2019","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.jconrel.2024.11.074_bb0035","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s00401-013-1125-6","article-title":"Protein aggregation in amyotrophic lateral sclerosis","volume":"125","author":"Blokhuis","year":"2013","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.jconrel.2024.11.074_bb0040","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.neuron.2013.07.033","article-title":"Converging mechanisms in ALS and FTD: disrupted RNA and protein homeostasis","volume":"79","author":"Ling","year":"2013","journal-title":"Neuron"},{"key":"10.1016\/j.jconrel.2024.11.074_bb0045","first-page":"2762","article-title":"The relevance of contact-independent cell-to-cell transfer of TDP-43 and SOD1 in amyotrophic lateral sclerosis","volume":"2017","author":"Hanspal","year":"1863","journal-title":"Biochim. Biophys. Acta Mol. basis Dis."},{"key":"10.1016\/j.jconrel.2024.11.074_bb0050","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1021\/acs.molpharmaceut.1c00297","article-title":"Non-viral vector-mediated gene therapy for ALS: challenges and future perspectives","volume":"18","author":"Ediriweera","year":"2021","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2024.11.074_bb0055","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.3390\/ijms19051345","article-title":"SOD1 in amyotrophic lateral sclerosis: \u201cambivalent\u201d behavior connected to the disease","volume":"19","author":"Pansarasa","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2024.11.074_bb0060","doi-asserted-by":"crossref","first-page":"14223","DOI":"10.1038\/s41598-018-31773-z","article-title":"Misfolded SOD1 pathology in sporadic amyotrophic lateral sclerosis","volume":"8","author":"Par\u00e9","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2024.11.074_bb0065","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s13024-015-0053-4","article-title":"SOD1 protein aggregates stimulate macropinocytosis in neurons to facilitate their propagation","volume":"10","author":"Zeineddine","year":"2015","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.jconrel.2024.11.074_bb0070","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1080\/14728222.2020.1738390","article-title":"Silence superoxide dismutase 1 (SOD1): a promising therapeutic target for amyotrophic lateral sclerosis (ALS)","volume":"24","author":"Abati","year":"2020","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.jconrel.2024.11.074_bb0075","doi-asserted-by":"crossref","first-page":"3558","DOI":"10.1172\/JCI99081","article-title":"Antisense oligonucleotides extend survival and reverse decrement in muscle response in ALS models","volume":"128","author":"McCampbell","year":"2018","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jconrel.2024.11.074_bb0080","doi-asserted-by":"crossref","DOI":"10.1177\/1756286418776932","article-title":"Antisense oligonucleotides in neurological disorders","volume":"11","author":"Wurster","year":"2018","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"10.1016\/j.jconrel.2024.11.074_bb0085","doi-asserted-by":"crossref","DOI":"10.1177\/1756285617734734","article-title":"Disease-modifying and symptomatic treatment of amyotrophic lateral sclerosis","volume":"11","author":"Dorst","year":"2018","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"10.1016\/j.jconrel.2024.11.074_bb0090","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/nrneurol.2017.148","article-title":"Antisense oligonucleotides: the next frontier for treatment of neurological disorders","volume":"14","author":"Rinaldi","year":"2018","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.jconrel.2024.11.074_bb0095","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s41591-021-01629-7","article-title":"New antisense oligonucleotide therapies reach first base in ALS","volume":"28","author":"Lopez","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.jconrel.2024.11.074_bb0100","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.neuron.2017.04.010","article-title":"Antisense oligonucleotides: translation from mouse models to human neurodegenerative diseases","volume":"94","author":"Schoch","year":"2017","journal-title":"Neuron"},{"key":"10.1016\/j.jconrel.2024.11.074_bb0105","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1038\/nbt.1957","article-title":"Astrocytes from familial and sporadic ALS patients are toxic to motor neurons","volume":"29","author":"Haidet-Phillips","year":"2011","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2024.11.074_bb0110","doi-asserted-by":"crossref","DOI":"10.1212\/NXG.0000000000000323","article-title":"Antisense oligonucleotides: a primer","volume":"5","author":"Scoles","year":"2019","journal-title":"Neurol. Genet."},{"key":"10.1016\/j.jconrel.2024.11.074_bb0115","first-page":"1","article-title":"Tofersen for SOD1 ALS, Neurodegenerative","author":"Everett","year":"2024","journal-title":"Dis. Manag."},{"key":"10.1016\/j.jconrel.2024.11.074_bb0120","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/s10038-022-01055-8","article-title":"Genetics of amyotrophic lateral sclerosis: seeking therapeutic targets in the era of gene therapy","volume":"68","author":"Suzuki","year":"2023","journal-title":"J. Hum. Genet."},{"key":"10.1016\/j.jconrel.2024.11.074_bb0125","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1056\/NEJMoa2204705","article-title":"Trial of antisense oligonucleotide Tofersen for SOD1 ALS","volume":"387","author":"Miller","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2024.11.074_bb0130","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1056\/NEJMoa2003715","article-title":"Phase 1\u20132 trial of antisense oligonucleotide tofersen for SOD1 ALS","volume":"383","author":"Miller","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2024.11.074_bb0135","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1146\/annurev-pharmtox-010716-104846","article-title":"Pharmacology of antisense drugs","volume":"57","author":"Bennett","year":"2017","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.jconrel.2024.11.074_bb0140","doi-asserted-by":"crossref","first-page":"3345","DOI":"10.1016\/j.ymthe.2021.04.008","article-title":"Gene therapy for ALS: a review","volume":"29","author":"Amado","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2024.11.074_bb0145","doi-asserted-by":"crossref","first-page":"3652","DOI":"10.1158\/0008-5472.CAN-12-0128","article-title":"Temporary disruption of the blood-brain barrier by use of ultrasound and microbubbles: safety and efficacy evaluation in rhesus macaques","volume":"72","author":"McDannold","year":"2012","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2024.11.074_bb0150","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1517\/17425247.2014.897693","article-title":"Drug delivery across the blood-brain barrier using focused ultrasound","volume":"11","author":"Burgess","year":"2014","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.jconrel.2024.11.074_bb0155","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1016\/j.ultrasmedbio.2012.04.015","article-title":"Improved anti-tumor effect of liposomal doxorubicin after targeted blood-brain barrier disruption by MRI-guided focused ultrasound in rat glioma","volume":"38","author":"Treat","year":"2012","journal-title":"Ultrasound Med. Biol."},{"key":"10.1016\/j.jconrel.2024.11.074_bb0160","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2019.01348","article-title":"Recent advances in the use of focused ultrasound for magnetic resonance image-guided therapeutic nanoparticle delivery to the central nervous system","volume":"10","author":"Fisher","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jconrel.2024.11.074_bb0165","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1038\/s41467-018-04529-6","article-title":"Blood\u2013brain barrier opening in Alzheimer\u2019s disease using MR-guided focused ultrasound","volume":"9","author":"Lipsman","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2024.11.074_bb0170","doi-asserted-by":"crossref","first-page":"4373","DOI":"10.1038\/s41467-019-12426-9","article-title":"First-in-human trial of blood\u2013brain barrier opening in amyotrophic lateral sclerosis using MR-guided focused ultrasound","volume":"10","author":"Abrahao","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2024.11.074_bb0175","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2017.00476","article-title":"Improving the delivery of SOD1 antisense oligonucleotides to motor neurons using calcium phosphate-lipid nanoparticles","volume":"11","author":"Chen","year":"2017","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.jconrel.2024.11.074_bb0180","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1039\/C6EN00136J","article-title":"Guidance to improve the scientific value of zeta-potential measurements in nanoEHS","volume":"3","author":"Lowry","year":"2016","journal-title":"Environ. Sci. Nano"},{"key":"10.1016\/j.jconrel.2024.11.074_bb0185","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/aja.1001940306","article-title":"Neuroblastoma x spinal cord (NSC) hybrid cell lines resemble developing motor neurons","volume":"194","author":"Cashman","year":"1992","journal-title":"Dev. Dyn."},{"key":"10.1016\/j.jconrel.2024.11.074_bb0190","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1146\/annurev-neuro-070918-050501","article-title":"Antisense oligonucleotide therapies for neurodegenerative diseases","volume":"42","author":"Bennett","year":"2019","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.jconrel.2024.11.074_bb0195","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1016\/j.ymthe.2017.06.002","article-title":"RNase H1-dependent antisense oligonucleotides are robustly active in directing RNA cleavage in both the cytoplasm and the nucleus","volume":"25","author":"Liang","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2024.11.074_bb0200","doi-asserted-by":"crossref","first-page":"2772","DOI":"10.1172\/JCI80705","article-title":"In vivo kinetic approach reveals slow SOD1 turnover in the CNS","volume":"125","author":"Crisp","year":"2015","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jconrel.2024.11.074_bb0205","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1002\/acn3.51784","article-title":"Protein kinetics of superoxide dismutase-1 in familial and sporadic amyotrophic lateral sclerosis","volume":"10","author":"Ly","year":"2023","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.jconrel.2024.11.074_bb0210","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/nrneurol.2016.13","article-title":"Ultrasound treatment of neurological diseases \u2013 current and emerging applications","volume":"12","author":"Leinenga","year":"2016","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.jconrel.2024.11.074_bb0215","doi-asserted-by":"crossref","first-page":"819","DOI":"10.4155\/tde.10.66","article-title":"Targeted drug delivery across the blood-brain barrier using ultrasound technique","volume":"1","author":"Deng","year":"2010","journal-title":"Ther. Deliv."},{"key":"10.1016\/j.jconrel.2024.11.074_bb0220","doi-asserted-by":"crossref","first-page":"344","DOI":"10.3390\/pharmaceutics7030344","article-title":"Enhancement of blood-brain barrier permeability and delivery of antisense oligonucleotides or plasmid DNA to the brain by the combination of bubble liposomes and high-intensity focused ultrasound","volume":"7","author":"Negishi","year":"2015","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2024.11.074_bb0225","doi-asserted-by":"crossref","first-page":"17720","DOI":"10.1038\/s41598-018-35677-w","article-title":"Safety evaluation of frequent application of microbubble-enhanced focused ultrasound blood-brain-barrier opening","volume":"8","author":"Tsai","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2024.11.074_bb0230","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1121\/1.3646905","article-title":"The mechanism of interaction between focused ultrasound and microbubbles in blood-brain barrier opening in mice","volume":"130","author":"Tung","year":"2011","journal-title":"J. Acoust. Soc. Am."},{"key":"10.1016\/j.jconrel.2024.11.074_bb0235","doi-asserted-by":"crossref","DOI":"10.3389\/fphy.2022.759749","article-title":"Simultaneous dual Echo gadolinium enhanced MR-PET for evaluation of PET tracer delivery in altered pathophysiology","volume":"10","author":"Cowin","year":"2022","journal-title":"Front. Phys."},{"key":"10.1016\/j.jconrel.2024.11.074_bb0240","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.jconrel.2009.11.008","article-title":"Biodegradable calcium phosphate nanoparticle with lipid coating for systemic siRNA delivery","volume":"142","author":"Li","year":"2010","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2024.11.074_bb0245","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/ng0596-43","article-title":"Motor neurons in cu\/Zn superoxide dismutase-deficient mice develop normally but exhibit enhanced cell death after axonal injury","volume":"13","author":"Reaume","year":"1996","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jconrel.2024.11.074_bb0250","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1126\/science.281.5384.1851","article-title":"Aggregation and motor neuron toxicity of an ALS-linked SOD1 mutant independent from wild-type SOD1","volume":"281","author":"Bruijn","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2024.11.074_bb0255","doi-asserted-by":"crossref","first-page":"918","DOI":"10.7150\/thno.14689","article-title":"Current and future theranostic applications of the lipid-calcium-phosphate nanoparticle platform","volume":"6","author":"Satterlee","year":"2016","journal-title":"Theranostics"},{"key":"10.1016\/j.jconrel.2024.11.074_bb0260","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1001\/archneur.65.4.nnr70007","article-title":"Gene-targeted therapies for the central nervous system","volume":"65","author":"Miller","year":"2008","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jconrel.2024.11.074_bb0265","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S1474-4422(13)70061-9","article-title":"An antisense oligonucleotide against SOD1 delivered intrathecally for patients with SOD1 familial amyotrophic lateral sclerosis: a phase 1, randomised, first-in-man study","volume":"12","author":"Miller","year":"2013","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jconrel.2024.11.074_bb0270","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1080\/1061186X.2017.1419360","article-title":"Lipid-coated calcium phosphate nanoparticle and beyond: a versatile platform for drug delivery","volume":"26","author":"Huang","year":"2018","journal-title":"J. Drug Target."},{"key":"10.1016\/j.jconrel.2024.11.074_bb0275","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1602\/neurorx.2.1.3","article-title":"The blood-brain barrier: bottleneck in brain drug development","volume":"2","author":"Pardridge","year":"2005","journal-title":"NeuroRx"},{"key":"10.1016\/j.jconrel.2024.11.074_bb0280","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1038\/jcbfm.2012.126","article-title":"Drug transport across the blood-brain barrier","volume":"32","author":"Pardridge","year":"2012","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.jconrel.2024.11.074_bb0285","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1021\/acscentsci.9b01299","article-title":"Understanding the uptake of nanomedicines at different stages of brain cancer using a modular nanocarrier platform and precision bispecific antibodies","volume":"6","author":"Houston","year":"2020","journal-title":"ACS Cent. Sci."},{"key":"10.1016\/j.jconrel.2024.11.074_bb0290","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.brs.2023.03.006","article-title":"Ultrasound\u2013enhanced brain delivery of edaravone provides additive amelioration on disease progression in an ALS mouse model","volume":"16","author":"Shen","year":"2023","journal-title":"Brain Stimul."},{"key":"10.1016\/j.jconrel.2024.11.074_bb0295","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/616197","article-title":"MRI-guided focused ultrasound as a new method of drug delivery","volume":"2013","author":"Thanou","year":"2013","journal-title":"J. Drug Deliv."},{"key":"10.1016\/j.jconrel.2024.11.074_bb0300","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.addr.2019.11.009","article-title":"The blood-brain barrier: physiology and strategies for drug delivery","volume":"165","author":"Pandit","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2024.11.074_bb0305","doi-asserted-by":"crossref","first-page":"9255","DOI":"10.1038\/s41598-019-45577-2","article-title":"Ultrasound-mediated blood-brain barrier opening enhances delivery of therapeutically relevant formats of a tau-specific antibody","volume":"9","author":"Janowicz","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2024.11.074_bb0310","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.jconrel.2020.05.040","article-title":"Secondary effects on brain physiology caused by focused ultrasound-mediated disruption of the blood\u2013brain barrier","volume":"324","author":"Todd","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2024.11.074_bb0315","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jconrel.2014.06.031","article-title":"Non-invasive delivery of stealth, brain-penetrating nanoparticles across the blood\u2212 brain barrier using MRI-guided focused ultrasound","volume":"189","author":"Nance","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2024.11.074_bb0320","doi-asserted-by":"crossref","first-page":"171","DOI":"10.14366\/usg.17021","article-title":"Ultrasound-guided drug delivery in cancer","volume":"36","author":"Mullick Chowdhury","year":"2017","journal-title":"Ultrasonography"},{"key":"10.1016\/j.jconrel.2024.11.074_bb0325","first-page":"492","article-title":"Immunohistochemical study on superoxide dismutases in spinal cords from autopsied patients with amyotrophic lateral sclerosis","volume":"18","author":"Shibata","year":"1996","journal-title":"Dev. Neurosci."},{"key":"10.1016\/j.jconrel.2024.11.074_bb0330","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1212\/01.wnl.0000188760.53922.05","article-title":"Rapid disease progression correlates with instability of mutant SOD1 in familial ALS","volume":"65","author":"Sato","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.jconrel.2024.11.074_bb0335","doi-asserted-by":"crossref","first-page":"253","DOI":"10.3389\/fncel.2013.00253","article-title":"An emerging role for misfolded wild-type SOD1 in sporadic ALS pathogenesis","volume":"7","author":"Rotunno","year":"2013","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.jconrel.2024.11.074_bb0340","first-page":"1","article-title":"Successful use of axonal transport for drug delivery by synthetic molecular vehicles","author":"Filler","year":"2008","journal-title":"Nat. Preced."},{"key":"10.1016\/j.jconrel.2024.11.074_bb0345","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1152\/physrev.00031.2020","article-title":"Fluid transport in the brain","volume":"102","author":"Rasmussen","year":"2022","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.jconrel.2024.11.074_bb0350","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/s41392-023-01588-0","article-title":"Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets","volume":"8","author":"Gao","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.jconrel.2024.11.074_bb0355","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.it.2020.07.007","article-title":"The role of astrocytes in CNS inflammation","volume":"41","author":"Giovannoni","year":"2020","journal-title":"Trends Immunol."},{"key":"10.1016\/j.jconrel.2024.11.074_bb0360","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/s41591-021-01615-z","article-title":"Antisense oligonucleotide silencing of FUS expression as a therapeutic approach in amyotrophic lateral sclerosis","volume":"28","author":"Korobeynikov","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.jconrel.2024.11.074_bb0365","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/s41591-021-01557-6","article-title":"Suppression of mutant C9orf72 expression by a potent mixed backbone antisense oligonucleotide","volume":"28","author":"Tran","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.jconrel.2024.11.074_bb0370","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/s41467-021-21112-8","article-title":"Variant-selective stereopure oligonucleotides protect against pathologies associated with C9orf72-repeat expansion in preclinical models","volume":"12","author":"Liu","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2024.11.074_bb0375","doi-asserted-by":"crossref","first-page":"3754","DOI":"10.7150\/thno.34388","article-title":"Repeated ultrasound treatment of tau transgenic mice clears neuronal tau by autophagy and improves behavioral functions","volume":"9","author":"Pandit","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.jconrel.2024.11.074_bb0380","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.7150\/thno.65539","article-title":"Claudin-5 binder enhances focused ultrasound-mediated opening in an in vitro blood-brain barrier model","volume":"12","author":"Chen","year":"2022","journal-title":"Theranostics"},{"key":"10.1016\/j.jconrel.2024.11.074_bb0385","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep33264","article-title":"Focused ultrasound-induced blood-brain barrier opening: association with mechanical index and cavitation index analyzed by dynamic contrast-enhanced magnetic-resonance imaging","volume":"6","author":"Chu","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2024.11.074_bb0390","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nmeth.2019","article-title":"Fiji: an open-source platform for biological-image analysis","volume":"9","author":"Schindelin","year":"2012","journal-title":"Nat. Methods"},{"key":"10.1016\/j.jconrel.2024.11.074_bb0395","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0056257","article-title":"Genetic deficiency of GABA differentially regulates respiratory and non-respiratory motor neuron development","volume":"8","author":"Fogarty","year":"2013","journal-title":"PLoS One"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365924008332?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365924008332?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T12:39:28Z","timestamp":1778243968000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365924008332"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":79,"alternative-id":["S0168365924008332"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2024.11.074","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lipid nanoparticles and transcranial focused ultrasound enhance the delivery of SOD1 antisense oligonucleotides to the murine brain for ALS therapy","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2024.11.074","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}